Immuneering to Collaborate with Astellas on Clinical Studies of Investigational CLDN18.2 Programs in Combination with Atebimetinib for Pancreatic Cancer Patients November 18, 2026
Faeth Therapeutics and Roche to Evaluate PIKTOR in Combination with a Selective Estrogen Receptor Degrader in HR+/HER2- Advanced Breast Cancer November 18, 2026
Natera Announces Clinical Collaboration with Incyte on Interventional Ph 2 Study in CRC November 18, 2026
Calytrix Bio enters an agreement to be acquired by Lilly to advance outcomes for patients living with essential thrombocythemia and myelofibrosis November 18, 2026
Additional Long-Term Follow-Up Data from Ph 2 Study of Safusidenib in IDH1-Mutant Glioma Presented November 18, 2026
Astellas and Audax Biosciences Enter Exclusive Option and License Agreement for DAX-044 for Immuno-Oncology November 11, 2026
Helix 51 Company Saros Therapeutics Receives Second $2 Million Award to Advance Cancer Immunotherapy November 11, 2026
Boehringer Ingelheim and SBP Group enter partnership to advance next-generation cancer therapies November 11, 2026
Zenith Epigenetics and Lilly to collaborate on Registration Enabling Study of ZEN-3694 and Verzenio® (Abemaciclib) in NUT Carcinoma November 11, 2026
T-Therapeutics announces oversubscribed $133 million Series B financing to achieve clinical proof-of-concept for first-in-class TCR bispecific therapies in cancer and autoimmune disease November 11, 2026
Novocure enters clinical trial collaboration and supply agreement with Verastem Oncology to evaluate TTFields therapy, chemo and VS-7375 to treat pancreatic cancer November 4, 2026
Dren Bio Announces $350 Million Financing to Advance Dibotatug Toward Commercialization and Accelerate Development of Broader Pipeline November 4, 2026
Astellas and Audax Biosciences Enter Exclusive Option and License Agreement for DAX-044 November 4, 2026
Starton Therapeutics Signs Clinical Trial Agreement with the Stanford School of Medicine to Evaluate STAR-LLD Combo with Novel CAR-T for Multiple Myeloma November 4, 2026
Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621 October 28, 2026
Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209 October 28, 2026
Akeso Announces Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Ph 2/3 Clinical Trial Collaboration to Evaluate Ivonescimab in 1L BTC October 27, 2026
Vir Biotechnology and Gilead Sciences to Discover and Develop Novel PRO-XTEN® Dual-masked T-cell Engagers for Solid Tumors October 20, 2026
Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer October 20, 2026
Hansoh Pharma Announces Strategic Collaboration and License Agreement With Roche to Advance Novel ADC Portfolio October 20, 2026
Alentis and PinotBio announce collaboration to develop next-generation ADCs targeting claudin-1 October 20, 2026
Adlai Nortye Enters Clinical Collaboration with Lilly and Merck KGaA to Evaluate Combination of AN4035 and Cetuximab October 20, 2026